MedCity News
MARCH 12, 2025
I asked if I could purchase the brace myself and bring it to the surgery. The answer was an unequivocal no: the health insurers contracted rate required me to purchase the brace from the hospital as part of the procedure. The post A 2,100% Markup: My Battle with a Vastly Overpriced Knee Brace and U.S. Healthcare appeared first on MedCity News.
Evolve Your Success
MARCH 12, 2025
Breaking Into Medical Sales: Gina Torres’s Journey from Nurse to Industry Expert In this inspiring episode, Gina Torres, a seasoned peripheral vascular representative, shares her incredible transition from a peripheral vascular nurse to a top medical device sales expert at Shockwave. Discover how she leveraged her clinical background to drive innovation and improve patient outcomes, particularly in preventing amputations for those with peripheral arterial disease.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
MARCH 10, 2025
Familiar foes in the industry have claimed a slew of jobs in recent months.
European Pharmaceutical Review
MARCH 11, 2025
Bristol Myers Squibb has agreed a merger with 2seventy bio in a deal worth approximately $286 million. A year ago, 2seventy decided to exclusively focus on unlocking the value of Abecma, with the goal of delivering more time for people living with multiple myeloma and maximizing value for all stakeholders, stated Chip Baird, Chief Executive Officer, 2seventy bio.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Pharma Marketing Network
MARCH 13, 2025
Table of Contents The Impact of a Pharma Ad Ban on TV Digital Marketing as a Primary Alternative Leveraging Data-Driven Advertising Strategies Strengthening Direct-to-Consumer (DTC) Engagement The Impact of a Pharma Ad Ban on TV The potential for a pharma ad ban on TV has sparked intense discussions among marketing executives. If regulations change, pharmaceutical brands must rethink their advertising strategies to maintain visibility and patient engagement.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Pharmaceutical Technology
MARCH 10, 2025
AstraZeneca and Ionis are intensifying their competition with Alnylam by securing an EU approval for Wainzua.
PharmaVoice
MARCH 10, 2025
Experts say cost and other barriers present challenges to returning to U.S. shores.
European Pharmaceutical Review
MARCH 12, 2025
MSD has announced it has opened a new $1 billion vaccine manufacturing facility at its site in Durham, North Carolina, US. “Expanding our state-of-the-art manufacturing facility in Durham marks a significant milestone in our efforts to strengthen our production and manufacturing capabilities in the US,” commented Sanat Chattopadhyay, Executive Vice President and President, Merck Manufacturing Division.
Pharma Marketing Network
MARCH 16, 2025
Table of Contents Understanding Paid Social Media Campaigns in Pharma Marketing Key Benefits of Paid Social Media Advertising for Pharma Brands Best Practices for Optimizing Paid Social Media Campaigns Measuring Success: How to Track ROI and Engagement Understanding Paid Social Media Campaigns in Pharma Marketing Pharmaceutical marketing has evolved significantly with the rise of paid social media campaigns , enabling brands to reach healthcare professionals (HCPs), patients, and caregivers in w
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
MedCity News
MARCH 12, 2025
Roche will share in developing and commercializing petrelintide, a clinical-stage Zealand Pharma drug that activates the amylin receptor to spark weight loss. This agreement represents the highest total financial consideration in the obesity field to date. The post Roche Puts Up $1.65B to Partner With Zealand on Future Foundational Therapy for Obesity appeared first on MedCity News.
PM360
MARCH 12, 2025
Cedar Knolls, NJ March 12th, 2025 Nuvera, part of Inizio Engage, has launched an expanded set of data led, insights-driven client solutions and strengthened its dynamic leadership team under the guidance of Derek Cothran, all showcased in its newly launched website. Nuvera is a leading consulting firm dedicated to designing, building, and measuring patient and HCP treatment experiences for rare diseases, specialty medicines, and cell and gene therapeutics.
PharmaVoice
MARCH 13, 2025
HHS head Robert F. Kennedy Jr. has long been an opponent of pharma influence in government. U.S. lawmakers are asking whether unofficial Mar-a-Lago meetings point to a change of heart.
PharmaTimes
MARCH 17, 2025
Collaboration brings remote care to cancer patients
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharma Marketing Network
MARCH 13, 2025
Table of Contents Understanding the Role of AI in Pharma Marketing Key Benefits of AI Integration in Pharma Marketing AI-Powered Strategies for Pharma Marketers Overcoming Challenges in AI Adoption Understanding the Role of AI in Pharma Marketing The pharmaceutical industry is undergoing a digital transformation, and AI in pharma marketing is at the forefront of this evolution.
MedCity News
MARCH 11, 2025
Multiple myeloma cell therapy Abecma is the lone remaining asset of 2seventy Bio, which spun out from Bluebird Bio in 2021. 2seventy and Bristol Myers Squibb currently share in U.S. commercialization of Abecma. The post Bristol Myers Squibb Buys Out Cancer Cell Therapy Partner 2seventy Bio in $286M Deal appeared first on MedCity News.
pharmaphorum
MARCH 16, 2025
A sharp rise in measles cases in 2024 in Europe has led to widespread calls for a concerted effort to ramp up vaccination rates
PharmaVoice
MARCH 11, 2025
Emalex Biosciences is full steam ahead with a targeted 2026 approval and launch for its novel drug.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
MARCH 14, 2025
The venture aims to advance MeiraGTxs Parkinsons gene therapy through Phase III trials with up to $430m in funding from Hologen.
Pharma Marketing Network
MARCH 10, 2025
Introduction Social media advertising has become an essential part of pharmaceutical marketing, offering direct access to healthcare professionals (HCPs), patients, and caregivers. However, paid social media campaigns in the pharmaceutical industry come with unique challenges, from strict regulatory guidelines to platform restrictions and audience targeting complexities.
MedCity News
MARCH 14, 2025
By creating meaningful connections, sharing caregiving responsibilities, and developing community-based solutions, communities can help older adults lead fulfilling lives. The post Intergenerational Relationships and Healthy Aging: Building Networks of Support appeared first on MedCity News.
PharmaTech
MARCH 10, 2025
The full tolerance coverage method is introduced as a coverage estimation approach for assessing the uniformity of dosage units from large sample sizes, ensuring that no dosage unit exceeds the specification range.
PharmaVoice
MARCH 13, 2025
The pharma giant announced a new partnership with BridGene Biosciences that will use its IMTAC platform for drug discovery.
Pharmaceutical Technology
MARCH 12, 2025
Ono Pharmaceuticals has secured the global rights to sapablursen, an RNA-targeting therapy by Ionis to treat polycythemia vera (PV).
Pharma Marketing Network
MARCH 11, 2025
Introduction Pharma marketing is constantly evolving, with new digital tools, regulatory updates, and data-driven strategies shaping the industry. Staying ahead requires access to reliable resources that help teams navigate the complexities of compliance, engagement, and campaign effectiveness. However, with so much information available, finding the right resources can feel overwhelming.
MedCity News
MARCH 11, 2025
Abarca Health is paying attention to specialty drugs, AI in healthcare, the impact of obesity-related conditions, and increased government regulations. The post 4 Prescription Drug Trends that are Top of Mind for One Abarca Exec appeared first on MedCity News.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
pharmaphorum
MARCH 12, 2025
Roche has parted with $1.4 billion upfront to secure rights to an obesity candidate developed by Zealand Pharma.
PharmaVoice
MARCH 17, 2025
The new $5.3 billion deal with the Swiss pharma giant gives Zealand a significant partner to advance its amylin analog obesity shot and create a new combination product.
PharmaTimes
MARCH 11, 2025
Oxford Medical Products targets overweight individuals
Expert insights. Personalized for you.
260 
Let's personalize your content